Ozempic is approved by the Food and Drug Administration (FDA) for the following uses: to improve blood sugar management in adults who have type 2 diabetes, when used along with diet and exercise to reduce the risk of major cardiovascular events (those related to the heart and blood vessels, such as heart attack, stroke, and death) in adults who have type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes The FDA has not approved Ozempic for weight loss or long-term weight management
topline obesity data has been released this way for the entire class
Kalra, S., Sahay, R., & Gupta, Y
The PlexusDx Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1, appetite regulation, and energy balance
Cannot be combined with manufacturer coupons or discount cards